"10.1371_journal.pone.0052870","plos one","2012-12-27T00:00:00Z","Francis M Ndungu; Jedidah Mwacharo; Domtila Kimani; Oscar Kai; Philippe Moris; Erik Jongert; Johan Vekemans; Ally Olotu; Philip Bejon","Kenya Medical Research Institute, Centre for Geographical Medical Research (Coast), Kilifi, Kenya; Nuffield Department of Clinical Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom; GlaxoSmithKline Biologicals, Wavre, Belgium; Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, United Kingdom","Conceived and designed the experiments: PM EJ JV AO PB. Performed the experiments: FMN JM DK OK PM EJ JV AO PB. Analyzed the data: FMN JM DK OK AO PB PM EJ JV. Wrote the paper: FMN JM PM EJ JV AO PB.","The authors have read the journal's policy and have the following conflicts: Dr. Vekemans, Philippe Moris, and Dr. Jongert report being employees of GlaxoSmithKline Biologicals; Dr. Vekemans report owning shares in GlaxoSmithKline. The rights to the patents covering the RTS,S malaria vaccine candidate, which include patents and patent applications related to International Patent Application Publication Nos. WO93/10152, WO2006/029887, WO2007/003384, WO2009/021931 and WO2009/080715, are assigned to GlaxoSmithKline Biologicals. Co-author Philip Bejon is a PLOS ONE Editorial Board member. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2012","12","Francis M Ndungu","FMN",9,TRUE,5,9,9,7,TRUE,TRUE,FALSE,0,NA,FALSE
